ETFIQData as of Nov 19, 2026. · etfiq.com/funds/mrny

MRNY Fact Sheet: YieldMax MRNA Option Income Strategy ETF

Share
$33.50
close, Nov 20, 2026

Over the year to Nov 19, 2026, MRNY returned +455.8% in total and charged 1.00% a year.

1-year total return
+480.3%
MRNA +772.1% to Nov 20, 2026
Expense ratio
1.00%
a year
Net assets
$228m
on Nov 19, 2026
Net flow, last 4 trading days
+$17.1m
daily basis to Nov 19, 2026

Growth of $10,000, 1 year

MRNY $55,583 +455.8% · MRNA $81,385 +713.9% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.

Returns

WindowTotal return
1 month−21.7%
3 months+23.8%
Year to date+391.8%
1 year+480.3%
3 years+61.2%

Total return, distributions reinvested, each window to Nov 20, 2026.

Facts

Synthetic covered call on MRNA, paying weekly · First traded Oct 24, 2023 · Benchmark Moderna (MRNA)

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, MRNY Fact Sheet: YieldMax MRNA Option Income Strategy ETF. Data as of Nov 19, 2026. https://etfiq.com/funds/mrny/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/mrny.